Clinical and Translational Science Collaborative of Northern Ohio, Systems Marketing Analysis for Research Translation (SMART) Innovation Program

项目摘要 面向科研翻译的系统营销分析(SMART)创新计划带来了一项尖端- 结合使用多种工具，提高临床和转化性研究的有效性、效率和公平性 从而加强公共卫生和保健服务的提供。SMART创新计划支持CTSA 通过(1)开发、示范和传播可改进的运营创新来实现计划目标 临床翻译的效率和效果，(2)结构化的、参与式的促进方法 合作伙伴关系和协作，以促进和加速当地、地区和 在全国范围内，以及(3)创建和提供这一点，明确强调解决健康差距和 将翻译科学的好处传递给所有人。更具体地说，我们建立在我们以前的集体经验基础上 和协作结合了基于社区的系统动力学，作为一种参与式的选择和 在新的基于集合的并发环境中使用社交营销方法定制实施策略 借鉴制造业的工程方法，加快转化性研究和健康公平。我们的 基本假设是参与式系统动力学模型与社会营销的整合 分析通过减少临床和转化研究的 翻译研究的复杂性。 SMART创新计划旨在与临床研究人员在 翻译研究连续体，重点是设计最大限度地 临床干预措施的保真度、可达性和可持续性的实施结果，以促进健康公平。 更具体地说，SMART创新计划从对创新的最终用户进行市场分析开始 (例如，患者在坚持服药的情况下，提供者在自杀筛查和转介的情况下)到 描述临床创新“需求”的初始分布及其对减少的潜在影响 健康不平等。这一初步分析为为期2.5天的参与式小组模型构建提供了基础 与临床研究人员、实施研究人员和最终用户(或代理人，例如患者)一起举办研讨会 导航者、倡导者)将实现上下文概念化为一个系统，选择和定制实现 战略，并改进实施。然后，该程序通过一个 营销分析的第二阶段，导致更高效地转换临床和社区 创新以改善健康结果和健康公平。

PROJECT ABSTRACT The Systems Marketing Analysis for Research Translation (SMART) Innovation Program brings a cutting- edge set of tools together to improve clinical and translational research effectiveness, efficiency, and equity and thereby enhance public health and health care delivery. The SMART Innovation Program supports CTSA Program Goals by (1) developing, demonstrating, and disseminating an operational innovation that improves the efficiency and effectiveness of clinical translational, (2) a structured, participatory method for promoting partnerships and collaborations to facilitate and accelerate translational research projects local, regionally, and nationally, and (3) creating and providing this with an explicit emphasis on addressing health disparities and deliver the benefits of translational science to all. More specifically, we build on our collective prior experience and collaboration combining community based-system dynamics as a participatory method for selection and tailoring of implementation strategies with a social marketing approach within a novel set-based concurrent engineering approach borrowed from manufacturing to accelerate translational research and health equity. Our primary hypothesis is that the integration of participatory system dynamics modeling with social marketing analysis improves clinical and translational research effectiveness, efficiency, and equity by reducing the complexity of translational research. The SMART Innovation program is designed to work with clinical researchers at any stage of the translational research continuum with an emphasis on the design of implementation strategies that maximize implementation outcomes of fidelity, reach, and sustainability of clinical interventions to promote health equity. More specifically, the SMART Innovation program begins with market analysis of the end user of the innovation (e.g., patient in the case of medication adherence, provider in the case of suicide screening and referral) to characterize the initial distribution of “demand” for the clinical innovation and its potential impact on reducing health inequities. This preliminary analysis provides the basis for a 2.5-day participatory group model building workshop with clinical researchers, implementation researchers, and end-users (or proxies, e.g., a patient navigator, advocate) to conceptualize the implementation context as a system, select and tailor implementation strategies, and refine an implementation. The program then supports the refinement of the analysis through a second phase of marketing analysis, leading to a more efficient translation of clinical and community innovations to improve health outcomes and health equity.